Parsons MW - Search Results

1

Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.

Yassi N, Zhao H, Churilov L, Wu TY, Ma H, Nguyen HT, Cheung A, Meretoja A, Mai DT, Kleinig T, Jeng JS, Choi PMC, Duc PD, Brown H, Ranta A, Spratt N, Cloud GC, Wang HK, Grimley R, Mahawish K, Cho DY, Shah D, Nguyen TMP, Sharma G, Yogendrakumar V, Yan B, Harrison EL, Devlin M, Cordato D, Martinez-Majander N, Strbian D, Thijs V, Sanders LM, Anderson D, Parsons MW, Campbell BCV, Donnan GA, Davis SM; STOP-MSU Trial Investigators. Yassi N, et al. Among authors: parsons mw. Lancet Neurol. 2024 Jun;23(6):577-587. doi: 10.1016/S1474-4422(24)00128-5. Epub 2024 Apr 20. Lancet Neurol. 2024. PMID: 38648814 Clinical Trial.

2

Combined (1)H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome.

Parsons MW, Li T, Barber PA, Yang Q, Darby DG, Desmond PM, Gerraty RP, Tress BM, Davis SM. Parsons MW, et al. Neurology. 2000 Aug 22;55(4):498-505. doi: 10.1212/wnl.55.4.498. Neurology. 2000. PMID: 10953180 Clinical Trial.

3

Perfusion magnetic resonance imaging maps in hyperacute stroke: relative cerebral blood flow most accurately identifies tissue destined to infarct.

Parsons MW, Yang Q, Barber PA, Darby DG, Desmond PM, Gerraty RP, Tress BM, Davis SM. Parsons MW, et al. Stroke. 2001 Jul;32(7):1581-7. doi: 10.1161/01.str.32.7.1581. Stroke. 2001. PMID: 11441205 Clinical Trial.

4

Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging.

Davis SM, Donnan GA, Butcher KS, Parsons M. Davis SM, et al. Curr Opin Neurol. 2005 Feb;18(1):47-52. doi: 10.1097/00019052-200502000-00010. Curr Opin Neurol. 2005. PMID: 15655402 Review.

5

When to measure lipid profile after stroke?

Yan B, Parsons M, McKay S, Campbell D, Infeld B, Czajko R, Davis SM. Yan B, et al. Cerebrovasc Dis. 2005;19(4):234-8. doi: 10.1159/000084086. Epub 2005 Feb 22. Cerebrovasc Dis. 2005. PMID: 15731554

6

Clinical-diffusion mismatch predicts the putative penumbra with high specificity.

Prosser J, Butcher K, Allport L, Parsons M, MacGregor L, Desmond P, Tress B, Davis S. Prosser J, et al. Stroke. 2005 Aug;36(8):1700-4. doi: 10.1161/01.STR.0000173407.40773.17. Epub 2005 Jul 14. Stroke. 2005. PMID: 16020762

7

Elevated hematocrit is associated with reduced reperfusion and tissue survival in acute stroke.

Allport LE, Parsons MW, Butcher KS, MacGregor L, Desmond PM, Tress BM, Davis SM. Allport LE, et al. Among authors: parsons mw. Neurology. 2005 Nov 8;65(9):1382-7. doi: 10.1212/01.wnl.0000183057.96792.a8. Neurology. 2005. PMID: 16275824

8

Rapid assessment of perfusion-diffusion mismatch.

Butcher K, Parsons M, Allport L, Lee SB, Barber PA, Tress B, Donnan GA, Davis SM; EPITHET Investigators. Butcher K, et al. Stroke. 2008 Jan;39(1):75-81. doi: 10.1161/STROKEAHA.107.490524. Epub 2007 Dec 6. Stroke. 2008. PMID: 18063829 Clinical Trial.

9

Imaging the penumbra - strategies to detect tissue at risk after ischemic stroke.

Ebinger M, De Silva DA, Christensen S, Parsons MW, Markus R, Donnan GA, Davis SM. Ebinger M, et al. Among authors: parsons mw. J Clin Neurosci. 2009 Feb;16(2):178-87. doi: 10.1016/j.jocn.2008.04.002. Epub 2008 Dec 18. J Clin Neurosci. 2009. PMID: 19097909 Review.

10

Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window.

Parsons MW, Miteff F, Bateman GA, Spratt N, Loiselle A, Attia J, Levi CR. Parsons MW, et al. Neurology. 2009 Mar 10;72(10):915-21. doi: 10.1212/01.wnl.0000344168.05315.9d. Neurology. 2009. PMID: 19273826 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters